Diffuse large B-cell lymphoma: open trials in South Korea

18 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06091865
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Pusan National University Hospital, Busan · Inje University Busan Paik Hospital, Busan · Dong-A University Hospital, Busan · Keimyung University Dongsan Hospital, Daegu · Yeyungnam University Medical Center, Daegu · Gachon University Gil Medical Center, Incheon · Seoul St. Marys Hospital, Seoul · Samsung Medical Center, Seoul · Yeouido St. Marys Hospital, Seoul · Asan Medical Center, Seoul · St. Vincent Hospital - The Catholic University of Korea, Suwon
Registry updated 2026-11-04
NCT05139017
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Seoul National University Hospital-Oncology ( Site 0302), Seoul · Samsung Medical Center ( Site 0300), Seoul
Registry updated 2026-11-03
NCT05952024
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
Trial Treatment · Phase 2 · AstraZeneca
Busan · Daegu · Gyeongsangnam-do · Incheon · Jeonju · Seogu · Seoul · Suwon · Ulsan
Registry updated 2026-10-30
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 1973), Seoul · Seoul National University Hospital-Pediatrics ( Site 1972), Seoul
Registry updated 2026-10-30
NCT06500273
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Trial Treatment · Phase 2 · Allogene Therapeutics
National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Hwasun · Pusan National University Hospital, Seogu · Samsung Medical Center, Seoul · The Catholic University of Korea Yeouido St. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University, Seoul · Asan Medical Center, Seoul · Ajou University Hospital, Suwon
Registry updated 2026-10-30
NCT06717347
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Pusan National University Hospital ( Site 3804), Busan · Chungnam National University Hospital ( Site 3801), Daejeon · National Cancer Center- Center for Hemotologic malignancy ( Site 3806), Goyang-si · St.Mary's H., Youido ( Site 3805), Seoul · Asan Medical Center ( Site 3803), Seoul · Severance Hospital, Yonsei University Health System ( Site 3802), Seoul · Samsung Medical Center ( Site 3807), Seoul
Registry updated 2026-10-21
NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Trial Treatment · Phase 1 · Pfizer
Chungnam National University Hospital, Daejeon · Seoul National University Bundang Hospital, Seongnam · Ewha Womans University Mokdong Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-15
NCT06806033
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Trial Treatment · Phase 2 · Hoffmann-La Roche
Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul
Registry updated 2026-10-09
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Samsung Medical Center, GangnamGu · The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu · Severance Hospital Yonsei University Health System, SeodaemunGu · Pusan National University Hospital, Seogu · Seoul National University Hospital, Seoul · Asan Medical Center, SongpaGu
Registry updated 2026-10-05
NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Keimyung University - Dongsan Medical Center, Daegu · National Cancer Center, Goyang-si · Gachon University Gil Medical Center, Incheon · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Gangnam Severance Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-08-19
NCT06785818
Long-term Follow up Local Registry Study of Kymriah in South Korea
Research · Novartis Pharmaceuticals
Bundang Gu · Busan · Gyeonggi-do · Incheon · Jeollanam · Seongnam-si · Seoul · Ulsan
Registry updated 2026-07-30
NCT04836507
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Trial Treatment · Phase 1/2 · Curocell Inc.
The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-07-01
NCT04627753
Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
Trial Treatment · Phase 2 · Kim, Seok Jin
Samsung Medical Center, Seoul
Registry updated 2026-04-23
NCT07473167
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Trial Treatment · Phase 1/2 · TICAROS Co., Ltd.
Seoul National University Hospital, Seoul
Registry updated 2026-03-16
NCT07062627
Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma
Trial Treatment · Phase 2 · Hyungwoo Cho
Asan Medical Center, Seoul
Registry updated 2025-12-17
NCT07269639
Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma
Trial Treatment · Phase 1/2 · Seoul National University Hospital
Seoul National University Hospital, Seoul
Registry updated 2025-12-08
NCT06796517
Immunotherapy in Lymphoma
Research · Sung-Soo Park
Seoul St. Mary Hospital, Seoul · Yeoido St. Mary Hospital, Seoul
Registry updated 2025-01-28
NCT04502394
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Trial Treatment · Phase 1/2 · Kartos Therapeutics, Inc.
National Cancer Center, Goyang · Gachon University Gil Medical Center, Incheon · Samsung Medical Center, Seoul · Seoul St. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2022-08-04

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error